Is a complete FLGT research report available?

No complete published report is available for Fulgent Genetics, Inc. (FLGT) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Fulgent Genetics, Inc. (FLGT)

NASDAQ: FLGT · USD

$19.7

-0.31 (-1.6%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first FLGT analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	558.6M
Revenue (ttm)	320.3M
Net income (ttm)	-73.8M
EPS (ttm)	-$2.40
Shares out	28.4M
Volume	145,672
Beta	0.89

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 320.3M
Net income (ttm): -73.8M
EPS (ttm): -$2.40
Market cap: 558.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All FLGT indicators

Market & fundamental data

Available fields

205

Groups with data

Currency

USD

Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001674930
Company name	Fulgent Genetics, Inc.
Country	United States
Country code	US
Cusip	359664109
Employees	1,315
Employees Change	2%
Employees Change Percent	0.15
Enterprise value	$-35.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Diagnostics & Research
Industry PE	42.46
Industry PE Fwd	25.83
IPO Date	2016-09-29
Isin	US3596641098
Last refreshed	2026-07-25
Market cap	$558.6M
Market cap category	Small-Cap
Price	$19.67
Price currency	USD
Rev Per Employee	243,609.13x
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.59
Sic	8071
Symbol	FLGT
Website	https://www.fulgentgenetics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-13.21%
FCF yield	-20.26%
P/B ratio	0.54x
P/S ratio	1.74x
PS Forward	1.48x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-33.07%
EBITDA Margin	-25.51%
Gross margin	38.71%
Gross Profit	$124M
Gross Profit Growth	9.31%
Gross Profit Growth Q	-24.19%
Gross Profit Growth3 Y	-4.67%
Gross Profit Growth5 Y	-27.37%
Net Income	$-73.8M
Net Income Growth Years	0%
Pretax Margin	-26.31%
Profit Margin	-23.04%
Profit Per Employee	$-56,129
ROA	-5.37
Roa5y	7.85
ROCE	-9.93
ROE	-6.92
Roe5y	9.21
ROIC	-13.03
Roic5y	17.17

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	4.19%
Cagr3y	-21.07%
Cagr5y	-26.15%
EPS Growth Years	0
Revenue Growth	9.54x
Revenue Growth Q	-3.17x
Revenue Growth Years	1x
Revenue Growth3 Y	-4.25x
Revenue Growth5 Y	-16.16x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.27
Assets	$1.2B
Cash	$276.3M
Current Assets	$479M
Current Liabilities	$90.1M
Debt	$10.2M
Debt Equity	$0.01
Equity	$1B
Interest Coverage	-1,358
Liabilities	$112.2M
Long Term Assets	$677.3M
Long Term Liabilities	$22.1M
Net Cash	$594.4M
Net Cash By Market Cap	$106
Net Cash Growth	-26.26%
Net Debt Equity	$-0.57
Tangible Book Value	$842.1M
Tangible Book Value Per Share	$29.19
WACC	8.98

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.31
Net Working Capital	$115.3M
Quick ratio	3.91
Working Capital	$388.9M
Working Capital Turnover	$0.87

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.95%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	4.18%
200-day SMA	21.45
3Y total return	-50.84%
50-day SMA	18.89
50-day SMA vs 200-day SMA	50under200
5Y total return	-78.02%
All Time High	189.9
All Time High Change	-89.64%
All Time High Date	2021-02-09
All Time Low	2.73
All Time Low Change	621.83%
All Time Low Date	2017-11-07
ATR	0.67
Beta	0.89
Beta1y	0.37
Beta2y	0.4
Ch YTD	-25.12
High	20.14
High52	31.04
High52 Date	2025-11-25
High52ch	-36.63%
Low	19.58
Low52	13.46
Low52 Date	2026-03-03
Low52ch	46.14%
Ma50ch	4.15%
Price vs 200-day SMA	-8.31%
RSI	49.07
RSI Monthly	46.29
RSI Weekly	50.89
Sharpe ratio	0.33x
Sortino ratio	0.51
Total Return	-0.95%
Tr YTD	-25.12
Tr1m	8.2%
Tr1w	-2.43%
Tr3m	22.71%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count Top	1
Analyst Price Target Top	$15
Analyst Ratings Top	Hold
Earnings EPS Estimate	$-0.51
Earnings Revenue Estimate	92,213,456x
Earnings Revenue Estimate Growth	12.73x
Operating Income	$-101.4M
Operating margin	-31.65
Price Target Change Top	$-23.74

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	17,564,794%
Float Percent	61.85%
Net Borrowing	-828,000
Shares Insiders	38.15%
Shares Institutions	62.52%
Shares Out	28,400,623
Shares Qo Q	-0.32%
Shares Yo Y	0.95%
Short Float	14.96%
Short Ratio	6.94
Short Shares	9.25

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-152.1M
Average Volume	254,177.7x
Bv Per Share	36.39
CAPEX	$-23.1M
Ch1m	8.2
Ch1w	-2.43
Ch1y	4.18
Ch3m	22.71
Ch3y	-50.84
Ch5y	-78.02
Ch6m	-29.3
Change	-1.55%
Change From Open	-1.55
Close	19.98
Days Gap	0
Depreciation Amortization	24,204,000
Dollar Volume	2,865,368.2
Earnings Date	2026-07-30
Earnings Time	amc
EBIT	$-105.9M
EBITDA	$-81.7M
EPS	$-2.4
F Score	2
FCF	$-113.2M
FCF EV Yield	316.29x
FCF Per Share	$-3.98
Financing CF	-48,450,000
Fiscal Year End	December
Founded	2,011
Goodwill	53,731,000
Income Tax	$-9.3M
Investing CF	94,581,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-01
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-27
Ma150	19.96
Ma150ch	-1.43%
Ma20	20.42
Ma20ch	-3.67%
Net CF	-43,882,000
Next Earnings Date	2026-07-30
Open	19.98
Optionable	Yes
Position In Range	16.07
Ppne	124,285,000
Price Date	2026-07-24
Ptbv Ratio	0.66
Relative Volume	0.57x
Revenue	320,346,000x
SBC By Revenue	12.15x
Share Based Comp	38,922,000
Tax By Revenue	-2.89x
Tr6m	-29.3%
Us State	California
Volume	145,672
Z Score	4.61

Fulgent Genetics, Inc. (FLGT)

Coverage state: Market snapshot only — no published research

Generate the first FLGT analysis

Price

Financial snapshot

Fair-value bridge

Latest news · FLGT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FLGT indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on FLGT

Frequently asked questions